KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clover Health Investments (CLOV) Amortization of Deferred Charges (2020 - 2022)

Clover Health Investments (CLOV) has disclosed Amortization of Deferred Charges for 3 consecutive years, with -$27000.0 as the latest value for Q4 2022.

  • For the quarter ending Q4 2022, Amortization of Deferred Charges fell 400.0% year-over-year to -$27000.0, compared with a TTM value of -$18000.0 through Dec 2023, changed N/A, and an annual FY2021 reading of $13.7 million, changed N/A over the prior year.
  • Amortization of Deferred Charges was -$27000.0 for Q4 2022 at Clover Health Investments, down from $9000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $18.7 million in Q3 2020 and bottomed at -$5.0 million in Q2 2020.
  • Average Amortization of Deferred Charges over 3 years is $3.2 million, with a median of $20000.0 recorded in 2021.
  • The sharpest move saw Amortization of Deferred Charges soared 173.15% in 2021, then crashed 400.0% in 2022.
  • Year by year, Amortization of Deferred Charges stood at $18.7 million in 2020, then crashed by 99.95% to $9000.0 in 2021, then plummeted by 400.0% to -$27000.0 in 2022.
  • Business Quant data shows Amortization of Deferred Charges for CLOV at -$27000.0 in Q4 2022, $9000.0 in Q3 2022, and $18000.0 in Q2 2022.